Related references
Note: Only part of the references are listed.Brentuximab vedotin in combination with bendamustine in pediatric patients or young adults with relapsed or refractory Hodgkin lymphoma
Luciana Vinti et al.
PEDIATRIC BLOOD & CANCER (2022)
Brentuximab vedotin and association with event-free survival (EFS) in children with newly diagnosed high-risk Hodgkin lymphoma (HL): A report from the Children's Oncology Group phase 3 study AHOD1331 (NCT 02166463).
Sharon M. Castellino et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma
Sharon M. M. Castellino et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Brentuximab Vedotin as Consolidation Therapy After Autologous Stem Cell Transplantation in Children and Adolescents (<18 y) With Early Relapse Hodgkin Lymphoma
Karen S. Fernandez et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2021)
Combination brentuximab vedotin and bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma
Christopher J. Forlenza et al.
BLOOD ADVANCES (2021)
Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study
David J. Straus et al.
BLOOD (2020)
Autologous hematopoietic cell transplantation for the treatment of relapsed/refractory pediatric, adolescent, and young adult Hodgkin lymphoma: a single institutional experience
Aimee C. Talleur et al.
BONE MARROW TRANSPLANTATION (2020)
The REDCap consortium: Building an international community of software platform partners
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2019)
Brentuximab vedotin as consolidation after hematopoietic cell transplant for relapsed Hodgkin lymphoma in pediatric patients
Jamie E. Flerlage et al.
PEDIATRIC BLOOD & CANCER (2019)
Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience
Lisa Giulino-Roth et al.
LEUKEMIA & LYMPHOMA (2018)
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma
J. M. Connors et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse
Craig H. Moskowitz et al.
BLOOD (2018)
Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1-2 trial
Peter D. Cole et al.
LANCET ONCOLOGY (2018)
Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study
Franco Locatelli et al.
LANCET HAEMATOLOGY (2018)
Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma
Lesley J. Scott
DRUGS (2017)
A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma
P. Satwani et al.
BONE MARROW TRANSPLANTATION (2015)
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial
Craig H. Moskowitz et al.
LANCET (2015)
Dose-Intensive Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents With Newly Diagnosed Intermediate-Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group Study AHOD0031
Debra L. Friedman et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
Anas Younes et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Management of relapsed and refractory classical Hodgkin lymphoma in children and adolescents
Stephen Daw et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Initial Response to Salvage Therapy Determines Prognosis in Relapsed Pediatric Hodgkin Lymphoma Patients
Monika L. Metzger et al.
CANCER (2010)
A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425
Cindy L. Schwartz et al.
BLOOD (2009)
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2009)
Salvage therapy of progressive and recurrent Hodgkin's disease:: Results from a multicenter study of the pediatric DAL/GPOH-HD study group
G Schellon et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: Results and prognostic indices
YE Lieskovsky et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Autologous stem cell transplantation for advanced Hodgkin's disease in children
A Verdeguer et al.
BONE MARROW TRANSPLANTATION (2000)
Share Paper
